| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |